Unexplained Infertility
41
3
4
24
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.4%
1 terminated out of 41 trials
96.0%
+9.5% vs benchmark
24%
10 trials in Phase 3/4
21%
5 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (41)
Vaginal Estradiol and Oral Guaifenesin in Clomiphene Ovulation Induction
Royal Jelly Supplementation in Unexplained Male Infertility
ICSI Versus Conventional IVF in Couples With Unexplained Infertility
Assessing the Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility
Uterine Scratching in Intra-Uterine Insemination
Cost-effective Treatment of Unexplained Infertility
Preovulatory Uterine Flushing With Saline as a Treatment for Unexplained Infertility
Elagolix for Fertility Enhancement Clinical Trial
Varicocelectomy in Patients With Clinical Varicocele and Unexplained Infertility
Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility
IUI With Letrozole Versus in Natural Cycle
New Protocol in Unexplained Infertility
Probiotic and Antibiotic Therapies in Women With Unexplained Infertility
A Therapeutic Protocol in Previous Failed ART Patients With High Total NK Cells
Incremental Clomiphene Citrate Doses in Successive Cycles and FSH, LH and Steroid Hormone Levels
Unexplained Infertility Treated by Hysteroscopy-laparoscopy
Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT
Assessment of Endometrial Thickness & Subendometrial Perfusion by 3D Power Doppler in Women With Unexplained Infertility and PCOS.
Treg, Th17 Cells, NKT in Epithelial Ovarian Tumor
Effect of Danazol on Endometrial αvβ3 Integrin Expression in Patients With Unexplained Recurrent Implantation Failure